CDEK
← All trials

NCT00314041

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jun 1, 1997
Primary completion
Apr 1, 1998
Completion date
Apr 1, 1998
First posted
—
Last posted
—
Enrollment
240
Arms / groups
— / —
Source
AACT · pre-existing

Sponsors

  • PfizerLead sponsor
  • WyethStudy director
  • WyethOverall official - principal investigator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.